Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nature

• Publication date

  1991-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/349414A0PMID 1846943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+

  2005cited by this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

  1990cited by this paper
• Uptake of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the N-methyl-4-phenylpyridinium ion (MPP+) into fetal mouse brain through the placenta.

  1989cited by this paper
• Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels.

  1989cited by this paper
• The role of excitatory amino acids and NMDA receptors in traumatic brain injury.

  1989cited by this paper
• Ultrastructural alterations induced by 1-methyl-4-phenylpyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro.

  1989cited by this paper
• Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.

  1989cited by this paper
• The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.

  1989cited by this paper
• Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

  1989cited by this paper
• The biodisposition of MPP+ in mouse brain.

  1989cited by this paper
• Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

  1988cited by this paper
• Determination of the pharmacokinetics of 2-amino-7-phosphonoheptanoate in rat plasma and cerebrospinal fluid.

  1988cited by this paper
• Beta-N-methylamino-L-alanine neurotoxicity: requirement for bicarbonate as a cofactor.

  1988cited by this paper
• The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse.

  1988cited by this paper
• Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists.

  1987cited by this paper
• Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin.

  1987cited by this paper
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+.

  1986cited by this paper
• 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway

  1986cited by this paper
• Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?

  1986cited by this paper
• The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem

  1986cited by this paper
• The Rat nervous system

  1985cited by this paper
• Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

  1985cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• Magnesium gates glutamate-activated channels in mouse central neurones

  1984cited by this paper
• L-Glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranes

  1984cited by this paper
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

  1984cited by this paper
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Uptake of a novel anticonvulsant compound, 2-amino-7-phosphono-[4,5-3H]heptanoic acid, into mouse brain.

  1983cited by this paper
• Synaptic activity mediates death of hypoxic neurons.

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system.

  1967cited by this paper
• NEUROLOGICAL DISEASE IN BOXERS.

  1963cited by this paper

• Neuroprotective Effect of Withaferin Derivatives toward MPP+ and 6-OHDA Toxicity to Dopaminergic Neurons.

  2025cites this paper
• Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel

  2023cites this paper
• Role of dopamine neuron activity in Parkinson's disease pathophysiology.

  2023cites this paper
• Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease

  2023cites this paper
• Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?

  2021cites this paper
• Critical amino acids in the TM2 of EAAT2 are essential for membrane‐bound localization, substrate binding, transporter function and anion currents

  2021cites this paper
• [Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19].

  2021cites this paper
• Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis

  2020cites this paper
• The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain.

  2020cites this paper
• MPTP toxicity causes vocal, auditory, orientation and movement defects in the echolocation bat.

  2020cites this paper
• Characterisation of metabotropic glutamate receptor 4 as a therapeutic target in Parkinson's disease

  2019cites this paper
• Focused ultrasound in Parkinson's disease: A twofold path toward disease modification

  2019cites this paper
• Early stages of Parkinson’s disease: aspects of the diagnosis and therapy

  2019cites this paper
• Ранние стадии болезни Паркинсона: особенности диагностики и терапии

  2019cites this paper
• Neurophysiology of the pedunculopontine tegmental nucleus.

  2019cites this paper
• Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

  2019influential citation
• Excitotoxicity

  2018cites this paper
• NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease

  2018cites this paper
• Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease Modeling

  2018cites this paper
• History and future challenges of the subthalamic nucleus as surgical target: Review article

  2018cites this paper
• A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity

  2018cites this paper
• Neuroprotective Properties of Glutamate Metabotropic Glutamate Receptors in Parkinson’s Disease and Other Brain Disorders

  2017cites this paper
• 11 Normal and Physio-Pathological Striatal Dopamine Homeostasis

  2017influential citation
• Role of glutamate N-Methyl-D-Aspartate receptor surface trafficking in the firing pattern of midbrain dopaminergic neurons

  2017cites this paper
• Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition.

  2017cites this paper
• MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/β-Catenin Signaling in Parkinsonian Rats.

  2017cites this paper
• Subtalamotomía como neuroprotección en la enfermedad de Parkinson. El papel de los ultrasonidos guiados por resonancia como cirugía temprana

  2016cites this paper
• Drug-induced neurotoxicity in addiction medicine: From prevention to harm reduction.

  2016cites this paper
• [Neuroprotective subthalamotomy in Parkinson's disease. The role of magnetic resonance-guided focused ultrasound in early surgery].

  2016cites this paper
• Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives

  2016cites this paper
• Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

  2016cites this paper
• In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.

  2016cites this paper
• Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease

  2016cites this paper
• THE EXPRESSION PATTERN OF DEATH ASSOCIATED PROTEIN KINASE1 IN NORMAL DORSAL ROOT GANGLION NEURONS AND FOLLOWING PERIPHERAL NERVE INJURY

  2015cites this paper
• 5-4-2010 AMP kinase-mediated activation of the BH 3-only protein Bim couples energy depletion to stress-induced apoptosis

  2015cites this paper
• Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons

  2015cites this paper
• Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders.

  2015cites this paper
• Amidation of 1-bromo-3,5-dimethyladamantane catalyzed with manganese compounds and complexes

  2015cites this paper
• Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.

  2015cites this paper
• In vitro dopaminergic neurotoxicity of pesticides: a link with neurodegeneration?

  2014cites this paper
• Advances in non-dopaminergic treatments for Parkinson's disease

  2014cites this paper
• Glutamate as a Neurotoxin

  2014cites this paper
• Therapeutic potential of targeting glutamate receptors in Parkinson’s disease

  2014cites this paper
• Endogenous Kynurenic Acid and Neurotoxicity

  2014cites this paper
• NEUROPROTEKCIJA U PARKINSONOVOJ BOLESTI

  2014cites this paper
• Poli(ADP-ribozil) polimeraza u životu i smrti živčanih stanica

  2014cites this paper
• MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease

  2014cites this paper
• Neuroprotective Effects of the MAO‐B Inhibitor, PF9601N, in an In Vivo Model of Excitotoxicity

  2014cites this paper
• Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease

  2014cites this paper
• A Nucleoprotein-Enriched Diet Suppresses Dopaminergic Neuronal Cell Loss and Motor Deficit in Mice with MPTP-Induced Parkinson’s Disease

  2014cites this paper
• Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.

  2014cites this paper
• Mental Disturbances in Parkinson's Disease and Related Disorders: The Role of Excitotoxins

  2014cites this paper
• Restorative Effect of Pioglitazone against MPTP Mediated Behavioural Deficits in Mice Model of Parkinson's Disease

  2014cites this paper
• Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons.

  2014cites this paper
• Survey of Selective Neurotoxins

  2014cites this paper
• Parkinson disease: from pathology to molecular disease mechanisms.

  2013cites this paper
• The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

  2013cites this paper
• Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons

  2013cites this paper
• DOCTOR OF PHILOSOPHY IN BIOTECHNOLOGY

  2013cites this paper
• Modulation of basal ganglia function by metabotropic glutamate receptors

  2013cites this paper
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish.

  2013cites this paper
• Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.

  2013cites this paper
• Assessment of Therapeutic Potential of Amantadine in Methamphetamine Induced Neurotoxicity

  2013cites this paper
• Author ' s personal copy Invited review Group III and subtype 4 metabotropic glutamate receptor agonists : Discovery and pathophysiological applications in Parkinson ’ s disease

  2013cites this paper
• Ampelopsis Radix Protects Dopaminergic Neurons against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Toxicity in Parkinson's Disease Models In Vitro and In Vivo

  2013cites this paper
• A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease

  2013cites this paper
• Acupuncture treatment for Parkinson's disease

  2013cites this paper
• 1‐Benzyl‐1,2,3,4‐Tetrahydro‐β‐Carboline as Channel Blocker of N‐Methyl‐d‐Aspartate Receptors

  2012cites this paper
• Moving towards predictive toxicology - a systems biology approach

  2012cites this paper
• Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.

  2012cites this paper
• Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.

  2012cites this paper
• Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease

  2012influential citation
• Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

  2012cites this paper
• Involvement of reactive oxygen species and high-voltage-activated calcium currents in nanoparticle zinc oxide-induced cytotoxicity in vitro

  2012cites this paper
• Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.

  2012cites this paper
• Normal and Physio-Pathological Striatal Dopamine Homeostasis

  2012influential citation
• Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

  2011cites this paper
• Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach.

  2011cites this paper
• Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

  2011cites this paper
• MPTP Mouse Models of Parkinson's Disease: An Update

  2011cites this paper
• Subthalamic Deep Brain Stimulation for Parkinson's Disease

  2011cites this paper
• Regulation and Pharmacological Manipulation of the Type 5 Metabotropic Glutamate (mGlu5) Receptor

  2011cites this paper
• Alzheimer’s Disease: Lessons from Cell Biology

  2011cites this paper
• Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.

  2011cites this paper
• Mechanisms of aluminium neurotoxicity in oxidative stress-induced degenerative processes in relation to parkinson's disease

  2011cites this paper
• Bone marrow cells differentiation to neurons in the rat brain using Serotonin and GABA:Their role on glutamate receptors, IP3, cAMP and cGMP functional regulation in unilateral Parkinsonism induced by 6-hydroxydopamine

  2011cites this paper
• AMP kinase–mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis

  2010cites this paper
• 9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.

  2010cites this paper
• Effect of nanocompounds on the modulation of adenosine and metabotropic glutamate receptors, on different in vitro models

  2010cites this paper
• EFECTO DE LOS PRETRATAMIENTOS SOLOS Y COMBINADO DE PROBENECID Y KINURENINA SOBRE EL DAÑO OXIDATIVO EN UN MODELO EXPERIMENTAL DE LA

  2010cites this paper
• 9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease

  2010cites this paper
• Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease

  2010cites this paper
• Neuronal and Mitochondrial Protection in Chronic Parkinsonism

  2010cites this paper
• An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease.

  2010cites this paper
• Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.

  2010cites this paper
• Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

  2010cites this paper
• Pre‐synaptic glutamate‐induced activation of DA release in the striatum after partial nigral lesion

  2010influential citation
• EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP

  2010cites this paper
• Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator*

  2009cites this paper